6. You are considering a geographic expansion into the European market for Canopy Pharmaceuticals. Below are the incremental cash flows for the Canopy project for you to use in your analysis. Assume Canopy's marginal tax rate is 35%, their cost of capital is 15.7 % and an expected growth rate of 5% after 2003. 1998 1999 2000 2001 2002 2003 Net Sales 8,500 15,000 35,500 46,000 52,000 60,000 24,400 Cost of Sales 3,100 5,500 13,900 18,000 20,000 Depreciation 100 100 100 100 100 100 SG&A 3,500 5,410 6,400 5,300 7,200 7,800 7,000 R&D 1,100 2,800 4,100 5,400 6,500 1,190 417 EBIT 700 11,000 17,200 18,200 20,700 Income Tax (35%) 6,370 245 455 3.850 6,020 7,245 Net Earnings Depreciation Operating Cash Flows 774 7,150 11,180 11,830 13,455 Net PPE (906) (2,030) (1394) (900) (800) (300) (200) Working Capital (780) (2457) (1267) (738) (912) Terminal Value Free Cash Flows

Essentials Of Investments
11th Edition
ISBN:9781260013924
Author:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Chapter1: Investments: Background And Issues
Section: Chapter Questions
Problem 1PS
icon
Related questions
Question

Estimate the free cash flows ('98-'03), the terminal value of the Canopy project in 2003 & the free cash flow, the NPV, the IRR, and the payback period.

**Educational Text on Incremental Cash Flows for Canopy Pharmaceuticals' Expansion**

---

In this exercise, you are analyzing the proposed geographic expansion into the European market for Canopy Pharmaceuticals. The table below details the incremental cash flows related to this project, which are crucial for your financial analysis. Important assumptions include Canopy’s marginal tax rate of 35%, a cost of capital of 15.7%, and an anticipated growth rate of 5% after 2003.

### Incremental Cash Flows (in thousands)

|            | 1998 | 1999  | 2000  | 2001  | 2002  | 2003  |
|------------|------|-------|-------|-------|-------|-------|
| **Net Sales**        | 8,500 | 15,000| 35,500| 46,000| 52,000| 60,000|
| **Cost of Sales**    | 3,100 | 5,500 | 13,900| 18,000| 20,000| 24,400|
| **Depreciation**     | 100  | 100   | 100   | 100   | 100   | 100   |
| **SG&A**             | 3,500 | 5,410 | 6,400 | 5,300 | 7,200 | 7,800 |
| **R&D**              | 1,100 | 2,800 | 4,100 | 5,400 | 5,600 | 7,000 |
| **EBIT**             | 700  | 1,190 | 11,000| 17,200| 18,200| 20,700|
| **Income Tax (35%)** | 245  | 417   | 3,850 | 6,020 | 6,370 | 7,245 |
| **Net Earnings**     | 455  | 774   | 7,150 | 11,180| 11,830| 13,455|
| **Depreciation**     | 100  | 100   | 100   | 100   | 100   | 100   |
| **Operating Cash Flows** | | | | | | |

#### Additional Cash Flow Considerations

- **Net PPE (Property
Transcribed Image Text:**Educational Text on Incremental Cash Flows for Canopy Pharmaceuticals' Expansion** --- In this exercise, you are analyzing the proposed geographic expansion into the European market for Canopy Pharmaceuticals. The table below details the incremental cash flows related to this project, which are crucial for your financial analysis. Important assumptions include Canopy’s marginal tax rate of 35%, a cost of capital of 15.7%, and an anticipated growth rate of 5% after 2003. ### Incremental Cash Flows (in thousands) | | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | |------------|------|-------|-------|-------|-------|-------| | **Net Sales** | 8,500 | 15,000| 35,500| 46,000| 52,000| 60,000| | **Cost of Sales** | 3,100 | 5,500 | 13,900| 18,000| 20,000| 24,400| | **Depreciation** | 100 | 100 | 100 | 100 | 100 | 100 | | **SG&A** | 3,500 | 5,410 | 6,400 | 5,300 | 7,200 | 7,800 | | **R&D** | 1,100 | 2,800 | 4,100 | 5,400 | 5,600 | 7,000 | | **EBIT** | 700 | 1,190 | 11,000| 17,200| 18,200| 20,700| | **Income Tax (35%)** | 245 | 417 | 3,850 | 6,020 | 6,370 | 7,245 | | **Net Earnings** | 455 | 774 | 7,150 | 11,180| 11,830| 13,455| | **Depreciation** | 100 | 100 | 100 | 100 | 100 | 100 | | **Operating Cash Flows** | | | | | | | #### Additional Cash Flow Considerations - **Net PPE (Property
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 3 steps

Blurred answer
Knowledge Booster
Capital Budgeting
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, finance and related others by exploring similar questions and additional content below.
Similar questions
Recommended textbooks for you
Essentials Of Investments
Essentials Of Investments
Finance
ISBN:
9781260013924
Author:
Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:
Mcgraw-hill Education,
FUNDAMENTALS OF CORPORATE FINANCE
FUNDAMENTALS OF CORPORATE FINANCE
Finance
ISBN:
9781260013962
Author:
BREALEY
Publisher:
RENT MCG
Financial Management: Theory & Practice
Financial Management: Theory & Practice
Finance
ISBN:
9781337909730
Author:
Brigham
Publisher:
Cengage
Foundations Of Finance
Foundations Of Finance
Finance
ISBN:
9780134897264
Author:
KEOWN, Arthur J., Martin, John D., PETTY, J. William
Publisher:
Pearson,
Fundamentals of Financial Management (MindTap Cou…
Fundamentals of Financial Management (MindTap Cou…
Finance
ISBN:
9781337395250
Author:
Eugene F. Brigham, Joel F. Houston
Publisher:
Cengage Learning
Corporate Finance (The Mcgraw-hill/Irwin Series i…
Corporate Finance (The Mcgraw-hill/Irwin Series i…
Finance
ISBN:
9780077861759
Author:
Stephen A. Ross Franco Modigliani Professor of Financial Economics Professor, Randolph W Westerfield Robert R. Dockson Deans Chair in Bus. Admin., Jeffrey Jaffe, Bradford D Jordan Professor
Publisher:
McGraw-Hill Education